Month: September 2024
Avo Launches EHR-Integrated AI Consult Tool
Avo Launches EHR-Integrated AI Consult Tool What You Should Know: – Avo, a provider of healthcare AI solutions, announces the…
Revelstoke Capital Partners Announces Significant Growth Investment in MediQuant
Revelstoke Capital Partners Announces Significant Growth Investment in MediQuant Revelstoke Capital Partners, a healthcare-focused private equity firm, today announced a…
Claim Denials Surge as Healthcare Providers Struggle with Tech Adoption
Claim Denials Surge as Healthcare Providers Struggle with Tech Adoption What You Should Know: – A new Experian Health study…
Morning Headlines 9/30/24
Morning Headlines 9/30/24 Epic calls on Particle Health to approve release of resolution … Epic calls on Particle Health to…
Monday Morning Update 9/30/24
Monday Morning Update 9/30/24 Top News Epic asks Carequality to publicly release its resolution … Top News Epic asks Carequality…
Bonus Features – September 29, 2024 – 50% of health systems say data quality hinders care quality improvement efforts, 60% of patients would be comfortable with AI supporting their doctor in a cancer diagnosis, plus 22 other stories
Bonus Features – September 29, 2024 – 50% of health systems say data quality hinders care quality improvement efforts, 60%…
Weekly Roundup – September 28, 2024
Weekly Roundup – September 28, 2024 Welcome to our Healthcare IT Today Weekly Roundup. Each week, we’ll be providing a…
Epic Challenges Particle Health Over Data Privacy Dispute
Epic Challenges Particle Health Over Data Privacy Dispute What You Should Know: – Epic Systems, a leading electronic health records…
SPACE-H Accelerator to Explore Astronaut Disease Treatment in Space
SPACE-H Accelerator to Explore Astronaut Disease Treatment in Space What You Should Know: – NaNotics LLC, a biopharmaceutical company developing NaNots®…
PACE-H Accelerator to Explore Astronaut Disease Treatment in Space
PACE-H Accelerator to Explore Astronaut Disease Treatment in Space What You Should Know: – NaNotics LLC, a biopharmaceutical company developing NaNots®…
